Usana Health Sciences, Inc., a Utah-based nutritional, skincare and dietary products manufacturer, indicates in its recently filed 8-K that it has substantially completed an internal investigation into whether the expense reimbursement policy and other practices at its Chinese affiliate, BabyCare Ltd., were compliant with the Foreign Corrupt Practices Act. The company reports that it is cooperating with the DOJ and the SEC in their investigations of the matter.
February 5, 2019
DOJ and SEC investigating nutritional supplement maker for possible FCPA violations
Related by Topic
New Post
Florida man receives 84 months in prison for role in money laundering and bribery scheme
October 31, 2025
News Alert
New Post
Spain grants United States’ request to extradite former UN official accused of accepting bribes
October 23, 2025
News Alert
New Post
Smartmatic charged in the Southern District of Florida for allegedly bribing a Philippine official
October 21, 2025
News Alert